AstraZeneca boss says transparency key for vaccine

24 September 2020 - The chief executive of AstraZeneca has said the public must trust that multiple regulators will review ...

Read more →

Taking steps toward transparency in real world evidence studies

22 September 2020 - The level of trust in health economics and outcomes research studies has been an on-going concern owing ...

Read more →

Update on the agenda for the November 2020 PBAC meeting

1 September 2020 - Less than one week in and the agenda for the next scheduled PBAC meeting has already been ...

Read more →

Insights from the July 2020 PBAC meeting - Insight #2 (agenda)

25 August 2020 - Agenda items are revised with no indication of what has been changed. ...

Read more →

Swiss data protection chief pushes back on drug pricing secrecy

20 August 2020 - A proposed change to the new health insurance law that seeks to keep drug prices under lock ...

Read more →

Italy becomes first country to require pharma to disclose public funding for R&D costs

6 August 2020 - Amid growing clamour for more transparency from the pharmaceutical industry, Italy has become the first country ...

Read more →

Health experts to FDA: make your vaccine deliberations public

5 August 2020 - A letter signed by nearly 400 health experts asked the agency to use its vaccine advisory panel ...

Read more →

2020 October price disclosure cycle – indicative prices

28 July 2020 - Indicative 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure have now been ...

Read more →

PBAC statement of endorsement for transparency measures and standardised redactions to public summary documents

23 July 2020 - The PBAC has made a statement outlining its support for measures to improve the transparency of ...

Read more →

Price disclosure October 2020 cycle outcomes summary

25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...

Read more →

US court nixes drug maker price disclosure

18 June 2020 - A US court has ruled against a move by President Donald Trump's administration to try to bring ...

Read more →

EMA weighs COVID-19 data transparency, not ready to resume full clinical data publication

1 June 2020 - In a response to officials at Germany’s IQWiG and the Cochrane Collaboration, EMA Executive Director Guido ...

Read more →

Emergency use authorisation of remdesivir: the need for a transparent distribution process

14 May 2020 - On 4 February 2020, the Secretary of the US Department of Health and Human Services (DHHS) determined ...

Read more →

FDA's drug approval system is more open than Australia's

11 May 2020 - Australia’s secretive drug approval system gives what some believe is an unfair advantage to rival drug companies. ...

Read more →

Agenda for the July 2020 PBAC meeting (revised)

1 May 2020 - Published on Wednesday and revised (with no notification) by Friday. ...

Read more →